BIEL has moved their offices to more leaner accommodations minus storage space for product. Chanel5 gave us the Politico article, https://www.politico.com/newsletters/future-p...h-00676874 - ACCESS … Advancing Chronic Care with Effective, Scalable Solutions. At the end of Chanel5’s post we have this - “Groups such as the American Medical Association (AMA), American College of Cardiology (ACC) and American Psychiatric Association (APA) have praised ACCESS.”.
Quote:… aims to bring down rates of high blood pressure, diabetes, chronic musculoskeletal pain and depression. Organizations that qualify for the program must offer a tech-forward approach to nutrition and behavioral support, medication management, and care coordination, as well as mental health therapy, in addition to usual clinician care. In exchange, they will receive some upfront payment based on patient conditions. They can only receive full payment if they improve patients’ health, like significantly reducing their high blood pressure, for example. “We want people to make money building these solutions,” said Oz. “But we want outcomes.”
Srinsocal, Post #346,756 gave us a patent for to "Remote Control Biology", Electrome Corporation AND Post #346,883 - BIEL files FDA Establishment Registration for 2026 Early. I do not recall BIEL ever being early with a Registration in the past. The only other company to file early in the PEMF codes was Well-Life.
Hawk05, Post #346,923 , from https://gust.com/companies/electrome
srinsocal, thru Post #346,972 , opined w/ this -Quote:Electrome is building the first integrated hardware-software platform for decoding and programming the electrical layer of human biology. Our AI-driven platform uses digital twins, frequency modeling, and patent-pending applicator devices to modulate cellular signals and deliver precision bioelectric therapies for pain, inflammation, infection, and cancer targeting a $152B global market -- with our first FDA-cleared product line launching Q1-26 .
What could possibly add to all this? Let’s see … maybe CMMS codes for reimbursement? I wonder what Keith Nalepka is up to nowadays??? So, in the final tally, we have the FDA, the AMA, the ACC, the APA, the CMMS (Dr. Oz), and, of course, the HHS RFK, Jr. are all on our side. These last few weeks have convinced me it is time to put your money on the table, if you have not already done so. Very quickly, I would really like to see a Christmas shareholder letter detailed enough to get people talking over the holidays. In the new year, make it official, and off we go.Quote:“If Electrome has Licensed BIEL's Technology and FDA Clearances rather than using BIEL as a manufacturing partner that could explain the exit of CICD and BIEL's new office with no warehouse.”
From Post #346,966 - I think the takeaway here is that we have an experienced Ophthalmologist, Dr. Nigel Timothy, who has invested hundreds of thousands $$$ in BIEL, and still holds over $500k in debt. He is also a consultant for Electrome. This reveals a new and likely theory as to how Electrome and BIEL hooked-up. This is also another confirmation that BIEL/Electrome is happening.
"Sic parvis magna" - Greatness from small beginningsQuote:THESE are the times that try men’s souls. The summer soldier and the sunshine patriot will, in this crisis, shrink from the service of their country; but he that stands it now, deserves the love and thanks of man and woman.
All the best, WBeacham